Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/16039
Full metadata record
DC FieldValueLanguage
dc.contributor.authorPanwar, R-
dc.contributor.authorHardie, M-
dc.contributor.authorBellomo, Rinaldo-
dc.contributor.authorBarrot, L-
dc.contributor.authorEastwood, Glenn-
dc.contributor.authorYoung, PJ-
dc.contributor.authorCapellier, G-
dc.contributor.authorHarrigan, PW-
dc.contributor.authorBailey, M-
dc.contributor.authorCLOSE Study Investigators-
dc.contributor.authorANZICS Clinical Trials Group-
dc.date.accessioned2016-06-15T04:13:14Z-
dc.date.available2016-06-15T04:13:14Z-
dc.date.issued2016-01-01-
dc.identifier.citationAmerican Journal of Respiratory and Critical Care Medicine. 2016;193(1): 43-51en_US
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/16039-
dc.description.abstractRATIONALE: There are no randomized controlled trials comparing different oxygenation targets for intensive care unit (ICU) patients. OBJECTIVES: To determine whether a conservative oxygenation strategy is a feasible alternative to a liberal oxygenation strategy among ICU patients requiring invasive mechanical ventilation (IMV). METHODS: At four multidisciplinary ICUs, 103 adult patients deemed likely to require IMV for greater than or equal to 24 hours were randomly allocated to either a conservative oxygenation strategy with target oxygen saturation as measured by pulse oximetry (SpO2) of 88-92% (n = 52) or a liberal oxygenation strategy with target SpO2 of greater than or equal to 96% (n = 51). MEASUREMENTS AND MAIN RESULTS: The mean area under the curve and 95% confidence interval (CI) for SpO2 (93.4% [92.9-93.9%] vs. 97% [96.5-97.5%]), SaO2 (93.5% [93.1-94%] vs. 96.8% [96.3-97.3%]), PaO2 (70 [68-73] mm Hg vs. 92 [89-96] mm Hg), and FiO2 (0.26 [0.25-0.28] vs. 0.36 [0.34-0.39) in the conservative versus liberal oxygenation arm were significantly different (P < 0.0001 for all). There were no significant between-group differences in any measures of new organ dysfunction, or ICU or 90-day mortality. The percentage time spent with SpO2 less than 88% in conservative versus liberal arm was 1% versus 0.3% (P = 0.03), and percentage time spent with SpO2 greater than 98% in conservative versus liberal arm was 4% versus 22% (P < 0.001). The adjusted hazard ratio for 90-day mortality in the conservative arm was 0.77 (95% CI, 0.40-1.50; P = 0.44) overall and 0.49 (95% CI, 0.20-1.17; P = 0.10) in the prespecified subgroup of patients with a baseline PaO2/FiO2 less than 300. CONCLUSIONS: Our study supports the feasibility of a conservative oxygenation strategy in patients receiving IMV. Larger randomized controlled trials of this intervention appear justified. Clinical trial registered with Australian New Zealand Clinical Trials Registry (ACTRN 12613000505707).en_US
dc.subjectCritical illnessen_US
dc.subjectIntensive careen_US
dc.subjectMechanical ventilationen_US
dc.subjectOxygen inhalation therapyen_US
dc.titleConservative versus liberal oxygenation targets for mechanically ventilated patients: pilot multicentre randomised trial.en_US
dc.typeJournal Articleen_US
dc.identifier.journaltitleAmerican Journal of Respiratory and Critical Care Medicineen_US
dc.identifier.affiliationIntensive Care Unit, John Hunter Hospital, Newcastle, Australiaen_US
dc.identifier.affiliationSchool of Medicine and Public Health, University of Newcastle, Newcastle, Australiaen_US
dc.identifier.affiliationDepartment of Intensive Care, Austin Hospital, The University of Melbourne, Melbourne, Australiaen_US
dc.identifier.affiliationAustralian and New Zealand Intensive Care Research Centre, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australiaen_US
dc.identifier.affiliationCritical Care Unit, University Hospital Besançon and University of Franche-Comté, Besançon, Franceen_US
dc.identifier.affiliationIntensive Care Unit, Wellington Hospital, Wellington, New Zealanden_US
dc.identifier.affiliationMedical Research Institute of New Zealand, Wellington, New Zealanden_US
dc.type.studyortrialRandomized Controlled Clinical Trial/Controlled Clinical Trialen_US
dc.identifier.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/26334785en_US
dc.identifier.doi10.1164/rccm.201505-1019OCen_US
dc.type.contentTexten_US
dc.type.austinJournal Articleen_US
local.name.researcherBellomo, Rinaldo
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.grantfulltextnone-
item.openairetypeJournal Article-
crisitem.author.deptIntensive Care-
crisitem.author.deptData Analytics Research and Evaluation (DARE) Centre-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

6
checked on Mar 28, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.